By
Jaclyn Jaeger2020-07-24T18:28:00
Taro Pharmaceuticals will pay a $205.7 million criminal penalty to resolve charges as part of the Justice Department’s ongoing investigation into the generic pharmaceutical industry.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2021-10-05T19:26:00Z By Jaclyn Jaeger
Three pharmaceutical manufacturers—Taro Pharmaceuticals USA, Sandoz, and Apotex Corp.—will pay a total of $447.2 million for alleged violations of the False Claims Act related to price-fixing.
2020-01-08T13:01:00Z By Jaclyn Jaeger
Compliance officers need to step it up in 2020; a world of heightened risk means a world of heightened regulatory oversight.
2025-12-31T12:00:00Z By Aaron Nicodemus and Oscar Gonzalez
This year’s compliance triumphs were all born out of compliance fails. In some cases, it was a regulator finding fault and demanding change. In others, acquiring companies noticed something a little fishy in their new acquisition. What formed a compliance triumph in every case wasn’t the mistake; it was the ...
2025-12-24T16:46:00Z By Jaclyn Jaeger
Companies that import goods into the United States will face heightened enforcement scrutiny for attempted acts of customs fraud, including tariff evasion, under the Trump administration. Thus, chief compliance officers and in-house counsel face a new kind of pressure to ensure they are mitigating risk in this area.
2025-12-24T13:54:00Z By Adrianne Appel
The chief operating officer of a plastic resin importer has pleaded guilty to intentionally falsifying documents to avoid paying tariffs on goods from China, the Department of Justice (DOJ) announced.
2025-12-23T21:50:00Z By Adrianne Appel
Federal investigators have announced progress in dismantling an online criminal operation that steals bank account information by mimicking legitimate bank websites.
Site powered by Webvision Cloud